Company intelligence / Profile preview
Beijing Fuyuan Pharmaceutical
Beijing, Beijing, Chinawansheng.com.cn ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company is focused on both first-to-market generics and rapid imitation of clinically urgent drugs. It has established a product group across major therapeutic areas such as cardiovascular and diabetes, with ongoing investment into innovation capacity. The company aims to develop up to 100 new products over ten years. All manufacturing facilities are GMP-compliant per Chinese national standards.
- Therapeutic areas
- EndocrinologyDermatologyNeurologyGastroenterologyCardiovascularNephrologyWomen's Health
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Beijing Fuyuan Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Fuyuan Pharmaceutical.